Table 1.
Day | 2 Outpatient Days | Move-in | 1 | 2 | 3 | 4 | 5 |
---|---|---|---|---|---|---|---|
Condition | Acute Effects | ‘Abstinence Initiation’* | Acute Effects | ||||
Cannabis | Exp-Administration | Self-Administration | Exp-Administration | ||||
Lorcaserin (mg BID) | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Day | 6 | 7 | 8 | 9 | 10 | 11 | Move-out |
Condition | Abstinence | ‘Relapse’ | |||||
Cannabis | None | Self-Administration | |||||
Lorcaserin (mg BID) | 10 | 10 | 10 | 10 | 10 | 10 | None |
Cannabis = 7.0% THC. Exp-Administration = Experimenter-administered: Each participant smoked 3 puffs of cannabis at no financial cost. Self-administration: Participants had the option of purchasing individual cannabis puffs. ‘Abstinence Initiation’: Cannabis self-administration following 0 days of cannabis abstinence. ‘Relapse:’ Self-administration following 3 days of cannabis abstinence.
Order of abstinence initiation and withdrawal/relapse conditions was counterbalanced, as were doses of lorcaserin (0, 10 mg BID).